XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document And Entity Information - shares
 3 Months Ended
Mar. 31, 2022
May 16, 2022
Document Information Line Items    
Entity Registrant Name MOONLAKE IMMUNOTHERAPEUTICS  
Trading Symbol MLTX  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Amendment Flag false  
Entity Central Index Key 0001821586  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Mar. 31, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q1  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Shell Company false  
Entity Ex Transition Period false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 001-39630  
Entity Incorporation, State or Country Code E9  
Entity Tax Identification Number 00-0000000  
Entity Address, Postal Zip Code N/A  
City Area Code 41  
Local Phone Number 415108022  
Entity Address, Address Line One Cormorant Asset Management  
Entity Address, Address Line Two LP 200 Clarendon Street  
Entity Address, Address Line Three 52nd Floor  
Entity Address, City or Town Boston  
Entity Address, State or Province MA  
Title of 12(b) Security Class A ordinary share, par value $0.0001 per share  
Security Exchange Name NASDAQ  
Entity Interactive Data Current Yes  
Class A Ordinary Shares    
Document Information Line Items    
Entity Common Stock, Shares Outstanding   36,925,639
Class B Ordinary Shares    
Document Information Line Items    
Entity Common Stock, Shares Outstanding   15,775,472